Pancreatic cancer risk after treatment of Hodgkin lymphoma.

@article{Dores2014PancreaticCR,
  title={Pancreatic cancer risk after treatment of Hodgkin lymphoma.},
  author={Graça M. Dores and Rochelle E Curtis and Flora E. van Leeuwen and Marilyn A Stovall and Per Hall and Charles F. Lynch and S. A. Smith and Rita E. Weathers and Hans Henrik Storm and David C Hodgson and Ruth A Kleinerman and Heikki Joensuu and Tom B{\o}rge Johannesen and Michael Andersson and Eric J. Holowaty and Magnus Kaijser and Eero Pukkala and Leila Vaalavirta and Sophie D Fossa and Fr{\o}ydis Langmark and Lois B Travis and Joseph F. Jr. Fraumeni and B M Aleman and Lindsay M. Morton and Ethel S. Gilbert},
  journal={Annals of oncology : official journal of the European Society for Medical Oncology},
  year={2014},
  volume={25 10},
  pages={
          2073-9
        }
}
  • G. Dores, R. Curtis, +22 authors E. Gilbert
  • Published 2014
  • Medicine
  • Annals of oncology : official journal of the European Society for Medical Oncology
BACKGROUND Although elevated risks of pancreatic cancer have been observed in long-term survivors of Hodgkin lymphoma (HL), no prior study has assessed the risk of second pancreatic cancer in relation to radiation dose and specific chemotherapeutic agents. PATIENTS AND METHODS We conducted an international case-control study within a cohort of 19 882 HL survivors diagnosed from 1953 to 2003 including 36 cases and 70 matched controls. RESULTS Median ages at HL and pancreatic cancer diagnoses… Expand
Increased pancreatic cancer risk following radiotherapy for testicular cancer
TLDR
A dose–response relationship exists between radiation to the pancreas and subsequent cancer risk, and persists for over 20 years, and should be considered when radiotherapy with exposure to the Pancreatic cancer patients is considered for newly diagnosed patients. Expand
Screening for Subsequent Pancreatic Cancer in Childhood Cancer Survivors is Needed. A Case Report
TLDR
It would be reasonable to introduce the same guidelines for screening of subsequent pancreatic cancer in childhood cancer survivors at high risk for subsequent pancreas cancer as proposed for patients with increased risk for familial pancreaticcancer. Expand
Second Cancer Risk Up to 40 Years after Treatment for Hodgkin's Lymphoma.
TLDR
The risk of second solid cancers did not appear to be lower among patients treated in the most recent calendar period studied (1989-2000) than among those treated in earlier periods. Expand
Long-Term Risk of Subsequent Malignant Neoplasms After Treatment of Childhood Cancer in the DCOG LATER Study Cohort: Role of Chemotherapy.
TLDR
It is strongly suggest that doxorubicin exposure in CCSs increases the risk of subsequent solid cancers and breast cancer, whereas cyclophosphamide exposure increases therisk of subsequent sarcomas. Expand
Second malignancy risk after treatment of Hodgkin Lymphoma
Second cancers are among the most serious sequelae of HL treatment because they cause substantial morbidity as well as mortality. Compared to the general population, HL survivors experienceExpand
Anthracyclines and Alkylating Agents: New Risk Factors for Breast Cancer in Childhood Cancer Survivors?
TLDR
Henderson et al are the first to show increased risk of breast cancer after exposure to anthracyclines and alkylating agents, in the absence of chest radiotherapy, and this is an important finding that could have clinical implications extending beyond the population of childhood cancer survivors treated withoutchest radiotherapy. Expand
Long-term risk of second malignancy and cardiovascular disease after Hodgkin lymphoma treatment.
TLDR
HL survivors need lifelong risk-based screening for selected second malignant neoplasms and CVDs, and preventive strategies should include lifestyle and drug-based interventions to minimize exposure to conventional risk factors for cancer andCVD. Expand
Trends in the Risks of Secondary Cancers in Patients With Hodgkin Lymphoma
TLDR
Although the overall risk of SCs in patients with HL declined after modifications in HL treatment, the risk did not change significantly at most individual sites, necessitating the need for ongoing targeted surveillance for SCs. Expand
Childhood Cancer: Occurrence, Treatment and Risk of Second Primary Malignancies
TLDR
An overview of the epidemiology and etiology of childhood cancers, current developments for their treatment, and therapy-related adverse late health consequences with a special focus on second primary malignancies is provided. Expand
Infradiaphragmatic irradiation and high procarbazine doses increase colorectal cancer risk in Hodgkin lymphoma survivors
TLDR
Colorectal cancer surveillance should be considered for HL survivors who received Infradiaphragmatic radiotherapy and a high cumulative procarbazine dose, according to a Dutch cohort of 5-year HL survivors treated between 1965 and 1995. Expand
...
1
2
3
4
...

References

SHOWING 1-10 OF 30 REFERENCES
Stomach cancer risk after treatment for hodgkin lymphoma.
TLDR
Patients with HL who received subdiaphragmatic radiotherapy had dose-dependent increased risk of stomach cancer, with marked risks for patients who also received chemotherapy containing high-dose procarbazine. Expand
Roles of radiation dose and chemotherapy in the etiology of stomach cancer as a second malignancy.
TLDR
Stomach cancer risk is strongly radiation dose dependent, and the role of chemotherapy, particularly of procarbazine and related agents, needs further study, because of the relatively small numbers of chemotherapy-treated subjects. Expand
Lung cancer following chemotherapy and radiotherapy for Hodgkin's disease.
TLDR
Past treatments with alkylating agents and radiation therapy for Hodgkin's disease were associated with an increased risk of lung cancer in a dose-dependent and additive fashion, but the precise risk estimates should be interpreted cautiously, given the possible residual and enhancing effects of tobacco. Expand
Breast cancer following radiotherapy and chemotherapy among young women with Hodgkin disease.
TLDR
Hormonal stimulation appears important for the development of radiation-induced breast cancer, as evidenced by the reduced risk associated with ovarian damage from alkylating agents or radiation. Expand
Secondary colorectal carcinoma after childhood cancer.
TLDR
In matched analyses, radiation and alkylator exposure are associated with secondary CRC, and this risk is proportional to dose and volume of radiation. Expand
Long-term solid cancer risk among 5-year survivors of Hodgkin's lymphoma.
  • D. Hodgson, E. Gilbert, +11 authors L. Travis
  • Medicine
  • Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • 2007
TLDR
Multivariable modeling demonstrates for the first time temporal changes in SC risk not evident in unadjusted analyses, and can facilitate the development of individualized risk assessment and the creation of screening strategies for early detection. Expand
Risk factors associated with secondary sarcomas in childhood cancer survivors: a report from the childhood cancer survivor study.
TLDR
Of the risk factors evaluated, radiation exposure was the most important for secondary sarcoma development in childhood cancer survivors; anthracycline chemotherapy exposure was also associated with increased risk. Expand
Chemotherapy and Thyroid Cancer Risk: A Report from the Childhood Cancer Survivor Study
TLDR
Treatments with alkylating agents increased thyroid cancer risk, but only in the radiation dose range less than 20 Gy, in which cell sparing likely predominates over cell killing. Expand
Gastrointestinal cancer after treatment of Hodgkin's disease.
TLDR
Patients treated for Hodgkin's disease are at modestly increased risk for secondary gastrointestinal cancer, especially after combined modality therapy and treatment at a young age, but was significantly elevated within 10 years. Expand
Second malignant neoplasms among long-term survivors of Hodgkin's disease: a population-based evaluation over 25 years.
  • G. Dores, C. Metayer, +14 authors L. Travis
  • Medicine
  • Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • 2002
TLDR
Although significantly elevated risks of stomach, female breast, and uterine cervix cancers persisted for 25 years, an apparent decrease in relative risk and AER of solid tumors at other sites is suggested. Expand
...
1
2
3
...